Can an eating disorder cause a low serum alkaline phosphatase level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Eating Disorders Cause Low Serum Alkaline Phosphatase?

Yes, eating disorders—particularly anorexia nervosa—can cause low serum alkaline phosphatase (ALP), with approximately 65% of adolescent patients demonstrating ALP levels below the normal range. 1

Epidemiology and Prevalence

  • Low alkaline phosphatase is a common biochemical finding in anorexia nervosa, occurring in approximately 65% of adolescent patients with the disorder 1
  • In contrast, alkaline phosphatase abnormalities were documented in only 7% of adult anorexia nervosa patients in one series, suggesting age-related differences in presentation 2
  • The low ALP appears to be relatively specific to restrictive eating disorders, as it was less commonly observed in other causes of malnutrition such as post-surgical anorexia or malignancy-related cachexia 2

Pathophysiologic Mechanisms

  • The low ALP in eating disorders reflects decreased bone turnover and reduced osteoblastic activity secondary to severe malnutrition and hormonal disruption 3
  • Energy deficiency leads to suppression of the hypothalamic-pituitary-gonadal axis, resulting in hypoestrogenism in females and hypogonadism in males, both of which impair bone formation 3
  • Low energy availability (typically <30 kcal/kg fat-free mass/day) triggers metabolic adaptations that reduce energy expenditure and disrupt bone metabolism 3
  • The combination of nutritional deficiency and hormonal suppression creates a state of low bone turnover, manifesting biochemically as reduced bone-specific alkaline phosphatase 3

Clinical Context and Associated Findings

  • Low ALP in eating disorders typically occurs alongside other metabolic abnormalities including decreased total protein (93% of patients), hypoglycemia (85%), and reduced globulins (78%) 2
  • Patients may also demonstrate elevated liver enzymes (AST, ALT, GGT) paradoxically alongside low ALP, reflecting hepatic dysfunction from malnutrition rather than cholestatic disease 2, 4
  • Hypophosphatemia is another common finding, particularly during refeeding, and can become severe enough to cause hemolytic anemia and cardiac changes 5
  • Zinc deficiency frequently coexists with eating disorders and may contribute to low ALP, as zinc is a cofactor for alkaline phosphatase enzyme activity 6

Diagnostic Implications

  • When evaluating unexplained low ALP in young patients, particularly females, eating disorders should be included in the differential diagnosis 1
  • The combination of low ALP with low body weight, amenorrhea (in females), and other signs of malnutrition strongly suggests anorexia nervosa 3
  • Initial psychiatric evaluation should include quantification of eating behaviors, weight control methods (restriction, purging, excessive exercise), and assessment of body image disturbance 3
  • Laboratory assessment should include a complete metabolic panel, complete blood count, and consideration of bone-specific markers if bone health is a concern 3

Clinical Significance for Bone Health

  • Low ALP in the context of eating disorders signals impaired bone formation and increased fracture risk, particularly concerning in adolescents who have not yet achieved peak bone mass 3
  • Osteopenia and reduced bone mineral density are common complications, with bone density associated with adherence to nutritional therapy 3
  • Premenopausal women with eating disorders and low BMD (Z-score ≤ -2.0) require evaluation to exclude secondary causes and should be considered for referral to an osteoporosis specialist 3
  • The relationship between low ALP and fracture risk in young patients with eating disorders is not as well-defined as in older populations, but the marker reflects underlying bone pathology 3

Management Considerations

  • Treatment requires a multidisciplinary approach including medical, psychiatric, psychological, and nutritional expertise to address both the eating disorder and its metabolic complications 3
  • For adolescents and emerging adults with anorexia nervosa, family-based treatment is recommended to normalize eating behaviors and restore weight 3
  • Nutritional rehabilitation should include adequate energy, protein, calcium, vitamin D, and consideration of zinc supplementation if deficiency is documented 3, 6
  • Monitoring of ALP during recovery can serve as a marker of improving bone turnover as nutritional status and hormonal function normalize 1

Important Caveats

  • Not all patients with eating disorders will demonstrate low ALP, and the absence of this finding does not exclude the diagnosis 2
  • Low ALP may normalize relatively quickly with refeeding, but bone density recovery takes much longer and may never fully normalize if peak bone mass was not achieved 3
  • During refeeding, severe hypophosphatemia can develop and requires close monitoring and supplementation to prevent life-threatening complications 5
  • The presence of elevated liver enzymes alongside low ALP should not be misinterpreted as cholestatic liver disease; this pattern is characteristic of malnutrition-related hepatic dysfunction in eating disorders 2, 4

References

Research

Metabolic abnormalities in adolescent patients with anorexia nervosa.

Journal of adolescent health care : official publication of the Society for Adolescent Medicine, 1985

Research

Biochemical abnormalities of the serum in anorexia nervosa.

The Journal of nervous and mental disease, 1988

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Biochemical abnormalities in anorexia nervosa and bulimia.

Annals of clinical biochemistry, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.